- IN₹1.23tn
- IN₹1.15tn
- IN₹257.74bn
- 97
- 19
- 94
- 83
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 24.09 | ||
| PEG Ratio (f) | 4.28 | ||
| EPS Growth (f) | 5.96% | ||
| Dividend Yield (f) | 0.74% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.34 | ||
| Price to Tang. Book | 5.29 | ||
| Price to Free Cashflow | 41.69 | ||
| Price to Sales | 4.56 | ||
| EV to EBITDA | 16.64 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 19.93% | ||
| Return on Equity | 18.76% | ||
| Operating Margin | 21.57% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 171,319.9 | 191,595.9 | 217,633.4 | 227,531.2 | 257,740.9 | 274,257.84 | 298,603.84 | 9.51% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -5.58 | +53.29 | +9.67 | +12.29 | +43.86 | +11.23 | +5.88 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cipla Limited is an India-based global pharmaceutical company. The Company is engaged in manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). The Company operates through two segments: Pharmaceuticals and New ventures. The Pharmaceuticals segment is engaged in developing, manufacturing, selling, and distributing generic or branded generic medicines, as well as Active Pharmaceutical Ingredients (API). The New ventures segment includes the operations of the Company, a consumer healthcare, Biosimilars and specialty business. Its product portfolio spans complex generics, as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS). Its geographical segments include India, the United States, South Africa, and the Rest of the World. It has its network of manufacturing, trading and other incidental operations in India and International markets.
Directors
- Yusuf Hamied NEC
- Umang Vohra CEO
- Samina Hamied VCH (45)
- M. Hamied NVC
- Kedar Upadhye CFO
- Paul Miller CEX
- Geena Malhotra CTO
- Pradeep Bhadauria CSO
- Rajendra Chopra CCO
- Swapn Malpani OTH
- Raju Mistry OTH
- Ranjana Pathak OTH
- Adil Zainulbhai LED
- S. Radhakrishnan NED
- Naina Kidwai NID (64)
- Punita Lal NID (58)
- Peter Mugyenyi NID
- Ramesh Rajagopalan NID
- Ashok Sinha NID
- Robert Stewart NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 17th, 1935
- Public Since
- November 3rd, 1994
- No. of Shareholders
- 445,004
- No. of Employees
- 27,764
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
National Stock Exchange of India- Shares in Issue
- 807,614,941
- Address
- Mumbai Central, MUMBAI, 400013
- Web
- https://www.cipla.com/
- Phone
- +91 2224826000
- Auditors
- Walker Chandiok & Co LLP
Upcoming Events for CIPLA
Q1 2026 Cipla Ltd Earnings Release
Cipla Ltd Annual Shareholders Meeting
Similar to CIPLA
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Cipla share price?
As of Today at 18:57 UTC, shares in Cipla are trading at IN₹1,524.05. This share price information is delayed by 15 minutes.
How has the Cipla share price performed this year?
Shares in Cipla last closed at IN₹1,524.05 and the price had moved by +2.89% over the past 365 days. In terms of relative price strength the Cipla share price has underperformed the S&P BSE 100 Index by -4.58% over the past year.
What are the analyst and broker recommendations for Cipla?
The overall consensus recommendation for Cipla is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Cipla dividend yield?
The Cipla dividend yield is 0.85% based on the trailing twelve month period.
Does Cipla pay a dividend?
Last year, Cipla paid a total dividend of IN₹13.00, and it currently has a trailing dividend yield of 0.85%. We do not have any data on when Cipla is to next pay dividends.
When does Cipla next pay dividends?
We do not have data on when Cipla is to next pay dividends. The historic dividend yield on Cipla shares is currently 0.85%.
How do I buy Cipla shares?
To buy shares in Cipla you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Cipla?
As of the previous close price of IN₹1,524.05, shares in Cipla had a market capitalisation of IN₹1.23tn.
Where are Cipla shares listed?
Here are the trading details for Cipla:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: CIPLA
What kind of share is Cipla?
Based on an overall assessment of its quality, value and momentum Cipla is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Cipla share price forecast for 2025?
The analyst consensus target price for shares in Cipla is IN₹1,631.55. That is 7.05% above the last closing price of IN₹1,524.05.
Analysts covering Cipla currently have a consensus Earnings Per Share (EPS) forecast of IN₹59.80 for the next financial year.
Find out moreWhat is the trend in the Cipla share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cipla. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +2.92%.
As of the last closing price of IN₹1,524.05, shares in Cipla were trading +0.11% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Cipla PE Ratio?
The Cipla PE ratio based on its reported earnings over the past 12 months is 24.09. The shares last closed at IN₹1,524.05.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Cipla?
Cipla's management team is headed by:
- Yusuf Hamied - NEC
- Umang Vohra - CEO
- Samina Hamied - VCH
- M. Hamied - NVC
- Kedar Upadhye - CFO
- Paul Miller - CEX
- Geena Malhotra - CTO
- Pradeep Bhadauria - CSO
- Rajendra Chopra - CCO
- Swapn Malpani - OTH
- Raju Mistry - OTH
- Ranjana Pathak - OTH
- Adil Zainulbhai - LED
- S. Radhakrishnan - NED
- Naina Kidwai - NID
- Punita Lal - NID
- Peter Mugyenyi - NID
- Ramesh Rajagopalan - NID
- Ashok Sinha - NID
- Robert Stewart - NID